search
Back to results

Evaluate the Clinical Efficacy of Whole Body Cryotherapy in the Cryosense Cabin for the Treatment of Fibromyalgia

Primary Purpose

Fibromyalgia

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Whole body cryotherapy sessions
Sponsored by
Tecnología e Innovación Médico Estética S.L.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Fibromyalgia focused on measuring Fibromyalgia, Whole body cryotherapy

Eligibility Criteria

25 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age between 25 and 80 years old
  • Diagnosis of Fibromyalgia according to ACR criteria
  • More than 1 year from diagnosis
  • Lack of response or partial response to previous treatment
  • In case of women,commitment not to get pregnant during the study.

Exclusion Criteria:

  • Patiens with cardiovascular or psychiatric comorbidity
  • Cold intolerance
  • Changes in pharmacological treatment during the study
  • Body temperature over 37,5ºC

Sites / Locations

  • Tecnología e Innovación Médico Estética

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

No Intervention

Arm Label

Whole Body Cryotherapy sessions

Control group

Arm Description

10 Whole Body Cryotherapy sessions administered on alternate days. Patient fills the questionaires and then comes into the cabin wearing only underwear. The door is closed and the session begins, with the release of nitrogen gas to the cabin indoors, which will be in contact with the patient's body surface for 3 minutes. The intervention is performed on alternate days, so 3 sessions per week are administered. Afterwards will be compared when intervening as an control group without sessions, and with 3 visits per week and fills in the questionnaires

Without sessions. Patient attends a control visit weekly, for 3 consecutive weeks and fills in the questionnaires to control the variables while treatment is not applied. Afterwards will be compared when intervening as an intervention group receiving 3 sessions per week and fills in the questionnaires.

Outcomes

Primary Outcome Measures

Fibromyalgia Impact Questionnaire (FIQ)
This instrument composed of 10 items, measures physical functioning, work status (missed days of work and job difficulty), depression, anxiety, morning tiredness, pain, stiffness, fatigue, and well-being over the past week.

Secondary Outcome Measures

Combined Index of Severity of Fibromyalgia (ICAF)
Composed of 59 items, measures the combined severity index of fibromyalgia divided into 4 factors: physical, emotional, social and active and passive coping
General health questionnaire (SF36)
It´s composed of 36 questions (items) that assess both positive and negative health states
Pain intensity measure. Visual Analogyc scale (VAS)
Each patien marks in the scale the pain intensity scored 0-10 (0= no pain; 10= pain as can be)

Full Information

First Posted
January 25, 2018
Last Updated
February 1, 2018
Sponsor
Tecnología e Innovación Médico Estética S.L.
search

1. Study Identification

Unique Protocol Identification Number
NCT03425903
Brief Title
Evaluate the Clinical Efficacy of Whole Body Cryotherapy in the Cryosense Cabin for the Treatment of Fibromyalgia
Official Title
Clinical Research, Randomized, Open, Unmasked, Controlled, Cross-group, Active-treatment, to Evaluate the Clinical Efficacy of Whole Body Cryotherapy (WBC) in the Cryosense TCT Cabin for the Treatment of Fibromyalgia
Study Type
Interventional

2. Study Status

Record Verification Date
February 2018
Overall Recruitment Status
Completed
Study Start Date
November 16, 2016 (Actual)
Primary Completion Date
June 9, 2017 (Actual)
Study Completion Date
June 9, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Tecnología e Innovación Médico Estética S.L.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to evaluate the effectiveness of an intervention with sessions of 3 minutes of whole body cryotherapy (WBC) in the Cryosense cabin. Measurement period time: 8 weeks.
Detailed Description
The aim of this study is to evaluate the effectiveness of an intervention with sessions of 3 minutes of whole body cryotherapy (WBC) in the Cryosense cabin, on the main clinical manifestations of patients with Fibromyalgia (FM). A randomized, open and crossed 8-week clinical trial comparing a WBC intervention with the waiting list control group. Patients diagnosed with FM according to ACR 2010 criteria, in treatment and regular follow-up recruited consecutively. Two groups were made, one of intervention and one of waiting list which served as control during the first phase. At the end of the first phase, and after a week of washout, the groups crossed and went on to carry out the second phase following the opposite intervention. The pharmacological treatment was not modified during the entire study. Trial endpoints were changed in pain after 2 and 4 weeks, measured by a visual analogue scale (VAS) and burden of disease, evaluated by the Fibromyalgia Impact Questionnaire(FIQ).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fibromyalgia
Keywords
Fibromyalgia, Whole body cryotherapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
All participants received WBC sessions and after that become controls
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Whole Body Cryotherapy sessions
Arm Type
Active Comparator
Arm Description
10 Whole Body Cryotherapy sessions administered on alternate days. Patient fills the questionaires and then comes into the cabin wearing only underwear. The door is closed and the session begins, with the release of nitrogen gas to the cabin indoors, which will be in contact with the patient's body surface for 3 minutes. The intervention is performed on alternate days, so 3 sessions per week are administered. Afterwards will be compared when intervening as an control group without sessions, and with 3 visits per week and fills in the questionnaires
Arm Title
Control group
Arm Type
No Intervention
Arm Description
Without sessions. Patient attends a control visit weekly, for 3 consecutive weeks and fills in the questionnaires to control the variables while treatment is not applied. Afterwards will be compared when intervening as an intervention group receiving 3 sessions per week and fills in the questionnaires.
Intervention Type
Device
Intervention Name(s)
Whole body cryotherapy sessions
Intervention Description
Whole body cryotherapy (WBC) 10 sessions of 3 minutes at a temperature of -196ºC (point of evaporation of liquid nitrogen), on the basis of three sessions a week.Fills in questionnaires.
Primary Outcome Measure Information:
Title
Fibromyalgia Impact Questionnaire (FIQ)
Description
This instrument composed of 10 items, measures physical functioning, work status (missed days of work and job difficulty), depression, anxiety, morning tiredness, pain, stiffness, fatigue, and well-being over the past week.
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Combined Index of Severity of Fibromyalgia (ICAF)
Description
Composed of 59 items, measures the combined severity index of fibromyalgia divided into 4 factors: physical, emotional, social and active and passive coping
Time Frame
8 weeks
Title
General health questionnaire (SF36)
Description
It´s composed of 36 questions (items) that assess both positive and negative health states
Time Frame
8 weeks
Title
Pain intensity measure. Visual Analogyc scale (VAS)
Description
Each patien marks in the scale the pain intensity scored 0-10 (0= no pain; 10= pain as can be)
Time Frame
8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age between 25 and 80 years old Diagnosis of Fibromyalgia according to ACR criteria More than 1 year from diagnosis Lack of response or partial response to previous treatment In case of women,commitment not to get pregnant during the study. Exclusion Criteria: Patiens with cardiovascular or psychiatric comorbidity Cold intolerance Changes in pharmacological treatment during the study Body temperature over 37,5ºC
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Javier Rivera, Doctor
Organizational Affiliation
Hospital Gregorio Marañón-IPR
Official's Role
Principal Investigator
Facility Information:
Facility Name
Tecnología e Innovación Médico Estética
City
Madrid
ZIP/Postal Code
28050
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30353267
Citation
Rivera J, Tercero MJ, Salas JS, Gimeno JH, Alejo JS. The effect of cryotherapy on fibromyalgia: a randomised clinical trial carried out in a cryosauna cabin. Rheumatol Int. 2018 Dec;38(12):2243-2250. doi: 10.1007/s00296-018-4176-0. Epub 2018 Oct 23.
Results Reference
derived

Learn more about this trial

Evaluate the Clinical Efficacy of Whole Body Cryotherapy in the Cryosense Cabin for the Treatment of Fibromyalgia

We'll reach out to this number within 24 hrs